Cystic fibrosis-related diabetes is associated with reduced islet protein expression of GLP-1 receptor and perturbation of cell-specific transcriptional programs.
囊性纖維化相關糖尿病與 GLP-1 受體的胰島蛋白表達減少及細胞特異性轉錄程序的擾動相關。
Sci Rep 2024-10-28
Human GLP1R variants affecting GLP1R cell surface expression are associated with impaired glucose control and increased adiposity.
影響 GLP1R 細胞表面表現的人類 GLP1R 變異與血糖控制不良和增加的脂肪堆積有關。
Nat Metab 2024-01-12
Glucagon-like peptide-1 receptor signaling modifies the extent of diabetic kidney disease through dampening the receptor for advanced glycation end products-induced inflammation.
葡萄糖樣肽-1 受體信號通路透過抑制高糖基產物受體誘導的發炎,調節糖尿病腎病變的程度。
Kidney Int 2024-01-08
ER stress and unfolded protein response (UPR) signaling modulate GLP-1 receptor signaling in the pancreatic islets.
內質網壓力和未摺疊蛋白反應(UPR)信號調節胰島中GLP-1受體信號。
Mol Cells 2024-03-08
Finerenone attenuates downregulation of the kidney GLP-1 receptor and glucagon receptor and cardiac GIP receptor in mice with comorbid diabetes.
Finerenone 減輕合併糖尿病小鼠腎臟 GLP-1 受體、胰高血糖素受體及心臟 GIP 受體的下調。
Diabetol Metab Syndr 2024-11-24
The role of the glucagon-FGF21 axis in improving beta cell function during glucose intolerance and SGLT2 inhibition.
在葡萄糖不耐症和 SGLT2 抑制期間,胰高血糖素-FGF21 軸在改善β細胞功能中的角色。
Diabetes Obes Metab 2024-12-02
Human subjects with impaired beta-cell function and glucose tolerance have higher levels of intra-islet intact GLP-1.
人類受試者在胰島素細胞功能和葡萄糖耐受性受損的情況下,具有較高水平的胰島內完整 GLP-1。
Metabolism 2024-12-03
Exploring the functional, protective, and transcriptomic effects of GIP on cytokine-exposed human pancreatic islets and EndoC-βH5 cells.
探討 GIP 對於細胞因子暴露的人類胰島及 EndoC-βH5 細胞的功能性、保護性及轉錄組效應。
Mol Cell Endocrinol 2025-03-23